<?xml version="1.0" encoding="UTF-8"?>
<p>Individuals with chronic respiratory infections, including TB, are first to experience the adverse effects of a pneumotropic pandemic, especially in the healthcare setting [
 <xref rid="B11" ref-type="bibr">11</xref>, 
 <xref rid="B12" ref-type="bibr">12</xref>]. Given that both coronavirus disease 2019 (COVID-19) and TB become important causes of mortality worldwide [
 <xref rid="B3" ref-type="bibr">3</xref>, 
 <xref rid="B6" ref-type="bibr">6</xref>, 
 <xref rid="B12" ref-type="bibr">12</xref>] and the TB endemic situation in Romania [
 <xref rid="B4" ref-type="bibr">4</xref>], we sought to explore the possible outcomes of the inevitable collide of the two pandemics. Considering SARS-CoV-2 high transmissibility, it is very likely that COVID-19 will be of particular concern for individuals infected with MTB [
 <xref rid="B13" ref-type="bibr">13</xref>]. Also, coinfection with MTB is of particular importance as the TB diagnosis might be missed or shadowed by concern about COVID-19.
</p>
